Special In Vitro Diagnostics Research Package

October 2001

In recent years molecular diagnostics has become a growing part of the clinical laboratory. The trend will not only continue but will show significant growth in the future. This report from Kalorama Information examines the current and future opportunities associated with Molecular Diagnostic Technologies. Areas covered include:

• Applications
• DNA-Based Technologies
  • Genomics
  • Amplification systems
  • Probe technologies
  • Chip-based technologies
• Protein-Based Technologies
  • Proteomics
  • Protein probes
  • Chip-based technologies

Market size and share for traditional Molecular Diagnostic products and the commercial outlook for new and/or emerging technologies.

The Worldwide Market for In Vitro Diagnostics

April 2002

This comprehensive report is a thorough overview of the in vitro diagnostics (IVD) industry worldwide, covering the breadth of traditional IVD testing (Kalorama released a report dedicated to the molecular diagnostics segment in the Fall of 2001). The Worldwide Market for In Vitro Diagnostic Tests will contain complete market statistics and analysis for all areas of IVD, including:

• Point-of-Care
• Clinical Chemistry
• Immunoassays
• Molecular Assays
• Hematology
• Coagulation
• Microbiology and Virology
• Blood Banking
• Tissue Banking and Transplantation, and
• Histology and Cytology

Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments will be discussed.

Asian In Vitro Diagnostics

October 2002

This report covers the five most important markets for in vitro diagnostics in Asia: Japan, China, India, Korea and Taiwan. The total market for diagnostics is broken down into six segments: Routine chemistry, critical care chemistry, hematology, urinalysis, coagulation and immunochemistry. The instruments working in each of the segments is summarized by company.

In chemistry, instrumentation is broken down by three levels of throughput. In critical care, instruments are divided by combination units and those doing blood gasses and those doing electrolytes. In hematology, cell counters are broken down by 5, 3, and no-diff systems. In urinalysis, strip readers are broken down by large and small instruments. In coagulation, instruments are broken down by automated and semi-automated. In immunochemistry, instruments are broken down by open and closed systems.

Market shares are provided for both instruments and reagents in all sectors. Profiles of the top ten players in each sector show the presence of that firm in the country; either by their own office or their local distributor. Finally, the report forecasts growth in both instrument and reagent sales.